Fastel

Quick links to important sections

Fastel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fastel

What is Fastel? A Foundational Overview

Property Description
Active ingredient Fexofenadine Hydrochloride
Form Tablet, Film-Coated Tablet, Oral Suspension
Pharmacological class Second-Generation Antihistamine
General purpose Relieving allergic manifestations
Origin Synthetic metabolite

Fastel: Classification as a Second-Generation Antihistamine

Fastel is a specific pharmaceutical entity whose activity is provided by the ingredient Fexofenadine Hydrochloride. It is classified as a second-generation antihistamine and functions as a selective peripheral H₁-receptor antagonist. This classification defines the drug as a synthetic compound derived from the older antihistamine, terfenadine, but structurally modified to eliminate cardiovascular risks and ensure a safer profile. As a single-ingredient product, Fastel's effect is exclusively attributed to the Fexofenadine component. Its development represents a significant step forward in allergy management compared to earlier chemical classes.


Composition, Forms, and General Therapeutic Purpose

The active component, Fexofenadine Hydrochloride, is responsible for the drug's therapeutic action, which involves blocking the effects of the naturally occurring substance, histamine. Fastel is designed for oral administration and is commonly available in several dosage forms, including the tablet, the film-coated tablet, and a liquid oral suspension. The overall general purpose of this medicine is to relieve the primary physical manifestations of allergic reactions by neutralizing histamine's effects on peripheral tissues. This medicine is often utilized for managing common allergic responses, such as those caused by seasonal pollen exposure. Because it minimally crosses the blood-brain barrier, a key characteristic of its pharmacological class, Fexofenadine is characterized by a low potential for causing drowsiness. This medicine provides symptom relief while allowing individuals to maintain cognitive function and alertness.

What side effects are possible with Fastel?

Possible Side Effects and Safety Information

The official safety information for Fastel (Fexofenadine Hydrochloride) is structured around adverse reactions documented in clinical trials and during post-marketing surveillance, classified by frequency and the physiological system affected.

Adverse Reaction Classification

Adverse effects are categorized by System-Organ-Class (SOC) and frequency, as reported in regulatory documents.

Classification Examples of Reactions
Common Headache, dizziness, nausea, drowsiness
Uncommon Fatigue
Rare / Not Known Insomnia, nervousness, nightmares, diarrhea, rash, pruritus (itching)

The SOC categories involved include Nervous System Disorders, Gastrointestinal Disorders, General Disorders, and Skin and Subcutaneous Tissue Disorders.


Serious Adverse Reactions and Safety Constraints

Post-marketing reports document rare but serious adverse reactions, primarily Hypersensitivity Reactions, which can include severe manifestations like angioedema (swelling) and systemic anaphylaxis. Additionally, Cardiac Disorders such as tachycardia (rapid heart rate) and palpitations have been noted.

  • Population Considerations: Individuals with renal impairment and older adults (geriatric population) may experience increased systemic exposure to Fexofenadine, a fact noted in official labeling. For pregnancy, the medicine was formerly designated as Category C by the FDA, indicating use only if the potential benefit justifies the potential risk.
  • Safety Restrictions: Co-administration with certain fruit juices (apple, grapefruit, orange) and aluminum- or magnesium-containing antacids is noted to reduce the drug's absorption and bioavailability. The medicine is contraindicated in patients with a known hypersensitivity to the active substance or its excipients.

Overdose and Emergency Response

Fastel Overdose and When to Seek Help

Reports of Fexofenadine Hydrochloride overdose have been infrequent and generally describe mild clinical manifestations. The officially documented signs following high exposure primarily relate to the Central Nervous System and anticholinergic effects. These symptoms include dizziness, drowsiness, fatigue, and dry mouth.

Overdose Status Regulatory Documentation
Documented Manifestations Dizziness, drowsiness, fatigue, dry mouth.
Antidote Availability No specific antidote is known.
Procedural Limitation Haemodialysis does not effectively remove Fexofenadine.

Immediate Actions and Required Medical Attention

Government health authorities mandate specific actions for suspected overdose. For a non-severe suspected overdose, the primary official action is to contact the poison control helpline immediately.

Urgent medical help is required if the affected individual exhibits severe clinical signs. You must immediately call emergency services if the person has collapsed, experienced a seizure, is having trouble breathing, or cannot be awakened.

Management of overdose is symptomatic and supportive. Healthcare professionals are advised to consider standard measures to remove any unabsorbed drug from the system. This approach reflects the fact that high-dose studies showed limited serious adverse effects compared to placebo.

Therapeutic Uses of Fastel

What Fastel Treats: Main Uses and Benefits

Fastel (Fexofenadine Hydrochloride) is generally used across conditions presenting with systemic or localized discomfort driven by allergic reactions. The medication is applied in conditions involving inflammatory or irritative processes, particularly for symptoms associated with Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (hives).


Symptom Management and Functional Support

Fastel is commonly applied across domains where additional symptomatic support is needed. It is applied in addressing symptom clusters that may become intense or disruptive, such as frequent sneezing, a runny nose, irritating redness and itching of the eyes, and intense skin itching (pruritus). This supports patients during episodes of heightened discomfort caused by environmental exposure or recurrent manifestations. This is relevant when symptoms interfere with daily functioning and maintaining alertness is important.


Symptom Support Overview

Key Indication Primary Symptom Relief Benefit Context
Chronic Hives Intense skin pruritus (itching) Helps improve day-to-day comfort during symptomatic periods.
Seasonal Allergies Sneezing, Rhinorrhea, Ocular Itching Contributes to easing the overall symptom burden.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Fastel?

The population eligibility for Fastel (Fexofenadine Hydrochloride) is strictly defined by regulatory authorities based on contraindications, age limits, and pre-existing health conditions.


Contraindications and Non-Eligibility

Fastel is contraindicated in patients with a known hypersensitivity (allergy) to fexofenadine or any of the product's inactive ingredients, representing an absolute exclusion from use.

Age-Specific Eligibility

  • Adults and Adolescents (ge12 years) are approved for use across primary indications.
  • Children 6 to 11 years of age are approved for use in both seasonal allergic rhinitis and chronic idiopathic urticaria.
  • Infants/Toddlers (ge6 months of age) are approved for chronic idiopathic urticaria, typically via the oral suspension formulation.

Conditional Use and Restrictions

Use is not recommended for breastfeeding mothers as the drug may pass into breast milk.

  • Pregnancy: Use is limited to cases where the potential benefit officially justifies the potential risk to the fetus, due to limited human safety data.
  • Renal Impairment: Patients with decreased kidney function require special consideration due to documented altered drug processing (higher plasma levels).
  • Cardiovascular Conditions: Patients with a history of or ongoing heart disease should use the medicine with caution, based on the class-related association with adverse cardiac events.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Exposure-Modifying Medicinal Products

The official regulatory profile identifies clinically significant pharmacokinetic interactions that alter Fastel's exposure in the bloodstream. Co-administration with the antibiotic Erythromycin or the antifungal Ketoconazole is documented to increase Fexofenadine systemic levels. For instance, Ketoconazole has been noted to increase the plasma concentration (C max and AUC) by over 130%. These effects are based on the documented influence of these medicines on specific drug transport systems, such as P-glycoprotein, which mediates the uptake and disposition of Fastel.

Timing and Absorption Restrictions

To prevent reduced gastrointestinal absorption, official labeling mandates specific timing rules. Aluminum- and magnesium-containing antacids interfere with absorption and must be taken at least two hours apart from Fastel administration. Furthermore, co-ingestion with common fruit juices (including grapefruit, apple, and orange) is restricted, as these beverages are documented to interfere with drug uptake transporters, resulting in a significant decrease in the medicine's bioavailability.

Population and Procedural Notes

The clearance of Fexofenadine is heavily reliant on renal function. Official labeling notes that patients with renal impairment experience substantially decreased clearance, which leads to increased systemic exposure. Fastel also has a pharmacodynamic effect of suppressing the cutaneous histamine response, necessitating a temporary cessation before skin allergen testing, as noted in the regulatory documents.

Mechanism of Action

How Fastel Works

Targeting Peripheral H1 Histamine Receptors

Fastel acts as a highly selective antagonist of the peripheral H1 histamine receptor. This molecular interaction prevents the body's naturally produced histamine from binding and activating the receptor, thereby interrupting the initial H1 receptor-mediated signaling sequence.


Modulating the Inflammatory Signaling Cascade

The blockade of the H1 receptor directly interrupts the downstream signaling cascade that mediates the acute humoral response in peripheral tissues. This mechanism limits the subsequent release of pro-inflammatory chemicals and modulates pathway activity that influences vascular permeability and sensory nerve activation.


Maintaining Peripheral Specificity

Fastel exhibits a strong peripheral pathway bias with minimal ability to cross the blood-brain barrier. This specificity ensures that the resulting physiological modulation of histamine-linked processes, such as changes in vascular fluid dynamics and peripheral nerve signaling, results from minimal access to the central nervous system (CNS).

Dosage and Administration Information

How to Use Fastel (Fexofenadine): Administration Guidelines

Fastel (fexofenadine) is administered orally and is taken according to a schedule based on age and renal function.


Dosage and Frequency

Population Standard Dose Frequency
Adults and Children ge 12 Years 60 mg OR 180 mg Twice Daily (BID) OR Once Daily (QD)
Children 6 to 11 Years 30 mg Twice Daily (BID)

Note on Renal Impairment: For adult and adolescent patients with decreased kidney function, the starting dose is adjusted to 60 mg once daily. Children with renal impairment also utilize a dose frequency of once daily administration (e.g., 30 mg QD for children 6-11 years).


Administration Requirements

  1. Ingestion: Swallow tablets with water only. Oral suspension is shaken well before measuring the dose.
  2. Fruit Juice Constraint: Fastel tablets or suspension are not taken with fruit juices (such as grapefruit, orange, or apple juice), as these beverages can decrease the absorption of fexofenadine.
  3. Antacid Separation: Fastel is not taken within approximately 2 hours of taking antacids that contain aluminum or magnesium. These antacids can interfere with the uptake of the medicine.
  4. Missed Dose: If a dose is missed, the next dose is taken at the regularly scheduled time. A double dose is not taken to make up for a missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fastel

The research evidence for Fastel (Fexofenadine Hydrochloride) is primarily derived from clinical trials focused on two major allergy-related conditions. These studies was studied for symptom patterns and other measured outcomes in observed populations under specific, controlled research conditions.


Evidence for Use in Seasonal Allergic Rhinitis (SAR)

The research into seasonal allergic rhinitis, commonly known as hay fever, has research examined multiple short-term randomized controlled trials (RCTs). These pivotal studies were designed to be double-blind and compare the medicine against an inactive substance (placebo). Researchers focused on monitoring physical symptoms over defined time intervals, typically lasting a few weeks.

In these studies, the primary measures used were patient-reported outcomes describing perceived discomfort, specifically the Total Symptom Score (TSS). This composite score was used by researchers to track measurements related to physical discomfort. Further research has explored functional outcomes, including measures of daily functioning and quality of life in populations experiencing fluctuating or unstable symptoms.

Evidence for Use in Chronic Idiopathic Urticaria (CIU)

Evidence for chronic idiopathic urticaria (chronic hives of unknown cause) has been established using similar intermediate-term RCTs, often lasting between four and six weeks. These studies applied in research contexts involving fluctuating or unstable symptoms.

Researchers primarily monitored two specific outcomes related to physical discomfort: the daily intensity of skin itching (pruritus) and the daily number of visible welts (wheals). Findings reported measurements of how these patient-reported outcomes evolved in the observed populations during the study period.


Research Focus on the Non-Sedating Profile

Specific research has studies monitored outcomes reflecting daily functioning or activity level. This research explored outcomes related to changes in cognitive and psychomotor function using specialized objective tests. This evidence contributes to the broader evidence landscape by highlighting changes measured during the study period, and findings help contextualize how patients reported their experience during the study period.

Key Limitations and Areas of Uncertainty

The majority of pivotal studies explored symptom measurements over defined short-term intervals, generally not exceeding six weeks. The evidence contributes to understanding symptom patterns only within these time intervals. Therefore, the long-term effects are not fully established.

Data for certain groups remain insufficient, especially for older adults and patients with specific underlying health conditions, such as impaired renal function. Research highlights what is known for episodes where symptoms become more noticeable, but evidence quality varies across studies due to methodological differences in older trials.

Key Studies & References

  1. Fexofenadine: Drug Information

Frequently Asked Questions (FAQ)

Common questions about Fastel (FAQ)

Q: Will Fastel make me feel sleepy or tired during the day?

Official safety information notes that drowsiness is a common side effect, and fatigue (a feeling of tiredness) is reported as an uncommon side effect. However, Fastel is specifically designed to have minimal access to the central nervous system, which is associated with a low potential for causing drowsiness compared to some older allergy medicines.

Q: How quickly does Fastel start working after I take it?

Regulatory information from clinical trials indicates that the relief of allergy symptoms can begin as early as 60 minutes after taking a single dose. The maximum effect of the medicine is typically seen between one to three hours after administration.

Q: How long does the effect of Fastel usually last?

The medicine is known to have a relatively long duration of action, typically lasting up to 24 hours. This long-lasting effect supports the different dosing schedules approved in official product information, which can include once-daily or twice-daily use.

Q: Can Fastel affect a person's ability to drive or operate machinery?

While the medicine has a low potential for causing drowsiness, both dizziness and drowsiness are listed as possible side effects in official documents. Official guidance documents indicate that patients should assess their individual response to the medication and exercise caution regarding driving or operating machinery if they experience drowsiness or dizziness.

Q: Does Fastel cause sleep disturbances like trouble sleeping or nightmares?

Official safety information notes that sleep disturbances, specifically insomnia (difficulty sleeping) and nightmares, have been reported as rare or unknown adverse reactions from post-marketing surveillance.

Q: What is the difference between the 60 mg, 120 mg, and 180 mg tablets?

The different strengths are associated with different administration frequencies and indications. For adults and adolescents, the 60 mg dose is often used for twice-daily administration, while the 180 mg dose is typically used for once-daily administration. The specific dose and frequency that is right for an individual is determined by a healthcare professional based on the approved indications and patient factors.

Q: Are there specific foods or drinks that can reduce how well Fastel works?

Official labeling restricts taking the medicine with common fruit juices (such as grapefruit, orange, or apple) because they can interfere with how the drug is absorbed. Official documentation notes that research has indicated that taking the tablet or capsule formulation with food may slightly decrease the amount of medicine absorbed into the body.

Q: Can Fastel be taken with or without food?

Regulatory guidance often advises taking the medicine with water only and avoiding fruit juices. Because food may decrease the amount of medicine absorbed into the body, some product labels reflect that the medicine's absorption is optimal when taken on an empty stomach.

Q: Can Fastel affect blood pressure or heart conditions?

Post-marketing reports document rare, serious adverse reactions involving the heart, such as rapid heart rate (tachycardia) and palpitations. For this reason, official labeling advises caution for patients with a history of heart disease. Research indicates the drug is less likely to cause specific heart rhythm issues than its chemical predecessor.

Q: What kind of symptoms does Fastel relieve the most effectively?

According to the official product labeling, the medicine is indicated to temporarily relieve allergy symptoms including sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat. It is also approved for use in relieving the symptoms of chronic hives (urticaria).

Q: Why are people with certain heart conditions sometimes advised to use caution with antihistamines?

Fastel belongs to a class of medicines whose older versions were known to cause heart-related side effects. Although Fastel was developed to minimize these specific risks, the class-related association with adverse cardiac events results in official advice that patients with pre-existing heart conditions should use the medicine with caution.

Q: Does Fastel contain any decongestants or other active ingredients?

According to the official product classification, Fastel (Fexofenadine Hydrochloride) is a single-ingredient product. It contains only fexofenadine as the active component and is not formulated with a decongestant or other active ingredients in this formulation.

Q: Can Fastel be used to help with a common cold or flu symptoms?

The approved uses of the medicine are limited to relieving symptoms associated with allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives). Official product information on approved uses does not include common cold or flu symptoms.

Q: Is there a risk of developing a tolerance to Fastel if I use it every day?

Clinical studies, including research lasting up to 28 days of continuous use, have generally indicated that there is no evidence of a loss of effectiveness (tolerance or tachyphylaxis) when it is used as directed on a daily basis.

How should Fastel be stored and disposed of?

How to Store and Dispose of Fastel (Fexofenadine)

The official storage requirements for Fastel (Fexofenadine) are based on maintaining product stability and integrity according to regulatory labeling.

Storage Conditions

Requirement Category Official Condition
Temperature Store at Controlled Room Temperature (20 to 25 C or 68 to 77 F).
Protection Protect from excessive moisture; the oral suspension must be kept from freezing.
Integrity Do not use after the expiry date or if the inner seal or blister units are torn.

Safety and Disposal

As a safety measure, the medicine must be kept out of the sight and reach of children.

Disposal must be managed properly: unused or expired medication must not be thrown away via wastewater or household waste.

Official instructions require individuals to ask a pharmacist for guidance on how to safely dispose of the medicine in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fastel found in:

A-Z Index: